TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Idexx Laboratories Norge AS
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,252
|
1,110
|
10,282 |
Financial expenses |
1
|
0
![]() |
0 |
Earnings before taxes |
248
|
210
|
170 |
Total assets |
2,781
|
2,365
|
2,960 |
Current assets |
2,749
|
2,322
|
2,891 |
Current liabilities |
1,402
|
1,092
|
1,783 |
Equity capital |
1,319
|
1,203
|
1,098 |
- share capital |
11
![]() |
11
|
12 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
47.4%
|
50.9%
|
37.1% |
Turnover per employee | |||
Profit as a percentage of turnover |
19.8%
|
18.9%
|
1.7% |
Return on assets (ROA) |
9.0%
|
8.9%
|
5.7% |
Current ratio |
196.1%
|
212.6%
|
162.1% |
Return on equity (ROE) |
18.8%
|
17.5%
|
15.5% |
Change turnover |
213
|
-8,632
|
1,533 |
Change turnover % |
20%
|
-89%
|
18% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.